Article

An Association Study Between VDR and HER2 in Breast Cancers Reveals the Potential of Combined Diagnosis and Prognosis

2021-10-05

Abstract excerpt

<h4>Background: </h4> Breast cancer is generally acknowledged as a heterogeneous disease, with complete characterization and underlying technologies available to predict outcomes. Biomarkers, especially the human epidermal growth factor receptor 2 (HER2), are keys to characterize breast cancer and optimize the patients’ clinical outcomes. Vitamin D has an anti-cancer effect in breast cancer, which is related to th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 018bfb56-ae34-57e4-a779-c8e8758665b7
DOI: 10.21203/rs.3.rs-940192/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

An Association Study Between VDR and HER2 in Breast Cancers Reveals the Potential of Combined Diagnosis and PrognosisDOI 10.21203/rs.3.rs-940192/v1Read

Development of a Prognostic Model for HR-positive HER2-negative and Node-negative Breast Cancer: Integrating Clinical and Transcriptional BiomarkersSemantic proximity Read

Analysis of the Prognosis Related Genes in HER2+ Breast Cancer Based on Weighted Gene Co-expression Network AnalysisSemantic proximity Read

Deciphering HER2 Breast Cancer Disease: Biological and Clinical ImplicationsSemantic proximity Read

Identification of key molecular targets that correlate with breast cancer through bioinformatic methods.Semantic proximity Read

Vitamin D and Breast Cancer: Mechanistic UpdateSemantic proximity Read

Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerSemantic proximity Read

MOBCdb: a comprehensive database integrating multi-omics data on breast cancer for precision medicineSemantic proximity Read

Research on therapeutic clinical trials including immunotherapy in Triple- negative Breast cancer: A bibliometric analysisSemantic proximity Read

Clinicopathological features and prognosis of HER2 low-expression breast cancer: a single-center retrospective studySemantic proximity Read

The Prognosis and Predictive Value of Estrogen Negative/Progesterone Positive (ER-/PR+) Phenotype: Experience of 1159 Primary Breast Cancer from a Single Institute.Semantic proximity Read

LINC02544 modulates the RAB/RAS signaling pathway by potential regulation of DENND2A expression level in the breast cancer patients: integrated bioinformatics and experimental analysesSemantic proximity Read

Trends in the Incidence and Survival of Women with Hormone Receptor-Positive Breast Cancer from 1990–2019: A Large Population-Based AnalysisSemantic proximity Read